Appili Pharmaceuticals ($APLIF): The Last COVID-19 Stock With Massive Upside - Under $50 Million Market Cap
Appili Pharmaceuticals (OTC: APLIF) is a dual-listed U.S. and Canadian company (also trades '$APLI' in Canada). At the time of this writing, $APLIF is at $0.98 a share with ~ $56 Million market cap.